NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/23/2025
Back to search
Official data from USPTO
CENTURY PHARMACEUTICALS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
09/23/2025
Trademark type
Combined
Nice classes
42
Filing date
07/06/2021
Registration date
09/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/23/2025
Last transaction
09/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/14/2024
First use in commerce
05/14/2024
Drawing code
3
Owner type
03
Owner location
Indianapolis, IN, US
Examiner
FLOWERS, JAY K
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a dark blue heart tilted to the left; light blue lobes of another heart being disposed to the lower right of the dark blue heart; the word "Century" in large stylized black font to the right of the dark blue heart and the light blue lobes; and "Pharmaceuticals, Inc". in smaller stylized black font below "Century"; all of the preceding on a white background.
Holders and representatives
Holders
Century Pharmaceuticals, Inc.
Representatives
Keith Swedo MERIDIAN IP LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Scientific laboratory services; none of the foregoing services relate to any cancer related pharmaceuticals
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/23/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/04/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/04/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/29/2025
IUAF
USE AMENDMENT FILED
05/14/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/14/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/14/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/03/2022
APET
ASSIGNED TO PETITION STAFF
10/31/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/13/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2022
PUBO
PUBLISHED FOR OPPOSITION
04/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/23/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/23/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/23/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/23/2022
DOCK
ASSIGNED TO EXAMINER
03/21/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/15/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/14/2021
NWAP
NEW APPLICATION ENTERED
07/09/2021
Continuous trademark protection
Get notified about every new filing that threatens CENTURY PHARMACEUTICALS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.